{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T04:04:27Z","timestamp":1746158667527,"version":"3.40.4"},"reference-count":22,"publisher":"Jaypee Brothers Medical Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.59556\/japi.73.0828","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T06:47:11Z","timestamp":1746082031000},"page":"13-15","source":"Crossref","is-referenced-by-count":0,"title":["Urinary Levels of Neutrophil Gelatinase-associated Lipocalin and Cystatin C in Patients with Hepatitis B on Tenofovir Treatment"],"prefix":"10.59556","volume":"73","author":[{"given":"Shivani","family":"Rani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himanshu","family":"Dandu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambuj","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahak","family":"Lamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wahid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virendra","family":"Atam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit","family":"Rungta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medhavi","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atin","family":"Singhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"key":"key20250501064706_B1","doi-asserted-by":"crossref","first-page":"5728359.","DOI":"10.1155\/2020\/5728359","article-title":"The risk of acute kidney injury in hepatitis B virus-related acute on chronic liver failure with tenofovir treatment.","volume":"2020:","author":"Zhang","year":"2020;","journal-title":"Biomed Res Int"},{"issue":"(3):","key":"key20250501064706_B2","doi-asserted-by":"crossref","first-page":"185\u2013","DOI":"10.1016\/S2468-1253(16)30024-3","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.","volume":"1","author":"Chan","year":"2016;","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"(3):","key":"key20250501064706_B3","doi-asserted-by":"crossref","first-page":"716\u2013","DOI":"10.1128\/AAC.46.3.716-723.2002","article-title":"Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors.","volume":"46","author":"Birkus","year":"2002;","journal-title":"Antimicrob Agents Chemother"},{"issue":"(12):","key":"key20250501064706_B4","doi-asserted-by":"crossref","first-page":"2743\u2013","DOI":"10.1128\/AAC.38.12.2743","article-title":"Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis.","volume":"38","author":"Martin","year":"1994;","journal-title":"Antimicrob Agents Chemother"},{"issue":"(2):","key":"key20250501064706_B5","doi-asserted-by":"crossref","first-page":"286\u2013","DOI":"10.3350\/cmh.2015.0066","article-title":"Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases.","volume":"22","author":"Cho","year":"2016;","journal-title":"Clin Mol Hepatol"},{"issue":"(10):","key":"key20250501064706_B6","doi-asserted-by":"crossref","first-page":"1519\u2013","DOI":"10.1681\/ASN.2012080857","article-title":"Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?","volume":"24","author":"Tourret","year":"2013;","journal-title":"J Am Soc Nephrol"},{"issue":"(1):","key":"key20250501064706_B7","doi-asserted-by":"crossref","first-page":"102\u2013","DOI":"10.1086\/524061","article-title":"Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy.","volume":"197","author":"Goicoechea","year":"2008;","journal-title":"J Infect Dis"},{"issue":"(Suppl 2):","key":"key20250501064706_B8","doi-asserted-by":"crossref","first-page":"S208.","DOI":"10.1016\/S0168-8278(12)60538-8","article-title":"525 tenofovir monotherapy for na\u00efve patients with chronic hepatitis B: a multicenter European study in clinical practice in 302 patients followed for 30 months.","volume":"56","author":"Lampertico","year":"2012;","journal-title":"J Hepatol"},{"issue":"(1):","key":"key20250501064706_B9","doi-asserted-by":"crossref","first-page":"14508.","DOI":"10.1038\/s41598-019-51053-8","article-title":"Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis.","volume":"9","author":"Jo","year":"2019;","journal-title":"Sci Rep"},{"issue":"(1):","key":"key20250501064706_B10","doi-asserted-by":"crossref","first-page":"95.e1\u2013","DOI":"10.1016\/j.cmi.2015.05.035","article-title":"Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.","volume":"22","author":"Tsai","year":"2016;","journal-title":"Clin Microbiol Infect"},{"issue":"(5 Suppl):","key":"key20250501064706_B11","doi-asserted-by":"crossref","first-page":"S185\u2013","DOI":"10.1002\/hep.22885","article-title":"Side effects of long-term oral antiviral therapy for hepatitis B.","volume":"49","author":"Fontana","year":"2009;","journal-title":"Hepatology"},{"issue":"(10):","key":"key20250501064706_B12","doi-asserted-by":"crossref","first-page":"873\u2013","DOI":"10.1097\/MCG.0000000000000325","article-title":"Renal function in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or entecavir monotherapy: a matched case-cohort study.","volume":"49","author":"Ha","year":"2015;","journal-title":"J Clin Gastroenterol"},{"issue":"(8):","key":"key20250501064706_B13","doi-asserted-by":"crossref","first-page":"941\u2013","DOI":"10.1016\/j.cgh.2012.04.008","article-title":"Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B.","volume":"10","author":"Gish","year":"2012;","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20250501064706_B14","first-page":"354908.","article-title":"Tenofovir nephrotoxicity: 2011 update.","volume":"2011:","author":"Fernandez-Fernandez","year":"2011;","journal-title":"AIDS Res Treat"},{"key":"key20250501064706_B15","doi-asserted-by":"crossref","first-page":"1273\u2013","DOI":"10.2147\/TCRM.S143286","article-title":"Renal safety of tenofovir and\/or entecavir in patients with chronic HBV monoinfection.","volume":"13:","author":"Yang","year":"2017;","journal-title":"Ther Clin Risk Manag"},{"key":"key20250501064706_B16","doi-asserted-by":"crossref","first-page":"167\u2013","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection.","volume":"57:","author":"European Association for the Study of the Liver.","year":"2012;","journal-title":"J Hepatol"},{"issue":"(4):","key":"key20250501064706_B17","doi-asserted-by":"crossref","first-page":"723\u2013","DOI":"10.1097\/QAD.0000000000002114","article-title":"Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women.","volume":"33","author":"Zhang","year":"2019;","journal-title":"AIDS"},{"key":"key20250501064706_B18","first-page":"129\u2013","article-title":"The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer.","volume":"1826:","author":"Chakraborty","year":"2012;","journal-title":"Biochim Biophys Acta"},{"key":"key20250501064706_B19","article-title":"Neutrophil gelatinase-associated lipocalin as a promising biomarker in acute kidney injury.","author":"Lima","year":"2020.","journal-title":"Inflammation in 21st Century;"},{"issue":"(1):","key":"key20250501064706_B20","article-title":"Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B.","volume":"21","author":"Li","year":"2021;","journal-title":"BMC Infect Dis"},{"key":"key20250501064706_B21","doi-asserted-by":"crossref","first-page":"e0128145.","DOI":"10.1371\/journal.pone.0128145","article-title":"Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.","volume":"10:","author":"Ariza","year":"2015;","journal-title":"PLoS One"},{"key":"key20250501064706_B22","doi-asserted-by":"crossref","first-page":"57\u2013","DOI":"10.1016\/j.jhep.2016.03.002","article-title":"Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis.","volume":"65:","author":"Ariza","year":"2016;","journal-title":"J Hepatol"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T06:47:14Z","timestamp":1746082034000},"score":1,"resource":{"primary":{"URL":"https:\/\/japi.org\/article\/japi-73-2-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.59556\/japi.73.0828"],"URL":"https:\/\/doi.org\/10.59556\/japi.73.0828","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}